A Study of Effects of Canagliflozin as Add-on Therapy to Insulin in the Treatment of Participants With Type 1 Diabetes Mellitus (T1DM)
Clinical trial NCT02139943 · COMPLETED
Trial details
- NCT number
- NCT02139943
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2015-06-01
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.